The latest news from Corcept Therapeutics on their Phase 3 GRACE clinical trial clinical trial is excellent. The drug relacorilant significantly reduced high blood pressure and blood sugar levels in people with endogenous Cushing’s syndrome.
For Professionals
This section offers content specifically designed for physicians and other healthcare professionals wishing to learn and share experiences with pituitary disease.
Pituitary Grand Rounds, episode two: a delayed diagnosis of Cushing’s disease
Double pituitary adenomas: a case from Dr. Blevins clinic.
Podcast and Video: In today’s podcast and accompanying video, Dr. Blevins discusses and illustrates the case of a patient with a double pituitary adenoma.
The Pituitary Society reacts to the controversial reclassification of pituitary adenomas to neuroendocrine tumors
From J D Faccinetti, chief editor co-founder – First, some background: the latest edition of the WHO (World Health Organization) Endocrine Tumors and Central Nervous System Tumors group reclassified pituitary adenomas as neuroendocrine tumors or
A recap of long-term follow-up practices for pituitary diseases.
From Lewis S Blevins, Jr. M.D. – Long-term follow-up of patients with pituitary disorders is essential for many reasons. Firstly, those patients who have been rendered disease-free are always at risk for recurrence. While long-term
Pseudo Cushing’s syndrome: a discussion and a case study
In today’s podcasts, Dr. Blevins talks about the genesis of pseudo Cushing’s syndrome and illustrates a fascinating case of pseudo Cushing’s syndrome due to alcohol ingestion.
Acromegaly: clinical insights in a new book
This book, edited by world-renowned clinicians and editors Dr. Manish Aghi and Dr. Lewis Blevins, delivers a guide to medical decision-making on diagnosing and treating acromegaly.
Another opportunity to share your opinion
COR2ED is an independent medical education company based in Europe. They have partnered with a scientific committee comprising endocrinologists, nurses, and patient advocacy groups (WAPO and INCA) to develop two surveys to explore the injection
Stanford study reports unprecedented success in cavernous sinus medial wall resection in patients with acromegaly; here’s another point of view
A commentary from Lewis S. Blevins Jr. M.D. – Dr. Lewis Blevins reviews a recent article published by Mohyeldin and others from Stanford University in Scientific Reports.
Minimally Invasive Skull Base Surgery: UCSF Case Studies
From Dr. Ezequiel (Eze) Goldschmidt and UCSF Health Medconnection a collection of minimally invasive skull base surgery cases. UCSF’s Ezequiel (Eze) Goldschmidt, MD, PhD, is a neurosurgeon specializing in minimally invasive techniques, including the endoscopic endonasal
The remarkable case of a giant pituitary adenoma
From the University of California, San Francisco, (UCSF) MedConnection comes a fascinating article about a patient with a giant pituitary adenoma removed via endoscopic endonasal surgery.
A case of a pituitary lesion (hemangiopericytoma)
In this podcast oriented to physicians, Dr. Lewis Blevins talks about a case of a patient with a pituitary lesion called a hemangiopericytoma invasive in the right cavernous sinus. Although the content is technical, patients and other interested parties may find the discussion interesting.
Recorlev®
In today’s podcast directed to physicians, PWN co-founder Dr. Lewis Blevins discusses the drug Recolev® (levoketoconazole) recently approved by the FDA to treat endogenous Cushing’s Syndrome.